Researchers from Wright State University in Ohio have identified a new culprit behind uncontrolled high blood pressure: zinc.

A team of researchers has developed a sugar-based stent that provides structural support during challenging microvascular suturing surgeries. The stent, which is 3D printed to match the diameters of specific arteries, fits inside the adjacent ends of a blood vessel while the stitching process takes place—and then quickly dissolves after blood flow resumes.

DUBLIN — January 24, 2019 — Medtronic plc (NYSE: MDT) today announced that it has entered into a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a privately-held medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias (irregular heartbeats), including atrial fibrillation (AF).

Patients with severe aortic regurgitation (AR) may be better off receiving valve operations before symptoms appear that “trigger” guideline recommendations for these surgeries, according to a new study in JACC: Cardiovascular Imaging.

Archeologists have uncovered evidence of atherosclerosis in a handful of 500-year-old mummies from Greenland, Forbes reported.

Having a romantic partner present—or even just calling up their image mentally—can help heart patients keep their blood pressure (BP) in check when dealing with stressful situations, according to research published in Psychophysiology.

Although the 2018 U.S. stroke guidelines recommended extending the window for endovascular thrombectomy (EVT) to 24 hours in select stroke patients, a new meta-analysis in JAMA Neurology serves as a reminder that prompt treatment remains crucial for achieving successful reperfusion.

A single-center study with more than a decade of follow-up supports the long-term efficacy of patent foramen ovale (PFO) closure for the prevention of recurrent ischemic events, showing only 1 percent of patients had an ischemic stroke and 2.9 percent experienced a transient ischemic attack.

The American Heart Association issued an urgent call to action Jan. 24, citing a “disturbing plateau” in CVD outcomes that’s stemmed from a lag in drug innovations, poorer quality of care and a rise in the prevalence of risk factors like obesity and hypertension.

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.